Homocystinuria due to cystathionine-f3-synthetase deficiency is the second most common inborn error of amino acid metabolism. It is an autosomal recessive disorder of methionine metabolism first described in 1962.' 2 Plasma homocysteine is increased, chiefly as the disulphide homocystine (homocysteinehomocysteine), and spills into the urine.' Plasma methionine is likewise increased and plasma cysteine and cystine are decreased. Two disorders of cystathionine-13-synthetase exist; both produce the same amino acid abnormalities and clinical features. One form responds to pharmacological doses of pyridoxine (vitamin B6), the other more common and more severe form is pyridoxine-unresponsive and requires a low-methionine diet supplemented with cystine.
countries screen for this disorder because of its variable, geographical incidence, which is as rare as 1 in 573 000 newborns in some European countries. 4 Untreated patients have ectopia-lentis, mental retardation, skeletal disorders and thromboembolic episodes' which can lead to death by 20 years of age. The major ocular complication is ectopia lentis, which probably occurs in up to 70% of patients by 8 years of age and in more than 95% by 40 years.' We describe the ocular findings in 19 patients with homocystinuria due to cystathionine-f-synthetase deficiency and correlate these findings with the age at commencement of treatment and biochemical -control.
Patients and methods
Nineteen patients with homocystinuria were studied. There were 10 males and nine females, aged 4 4 to 17 3 years. Fourteen patients were detected by screening (group 1; Table 1 ) and were on treatment from the first six weeks of life, while five patients began treatment in childhood (group 2; Table 2 ). The Guthrie microbiological inhibition assay for methionine was used for screening, performed on a dried blood spot between the third and sixth days of 427 John P Burke, Michael O'Keefe, Roger Bowell, and Eileen R Naughten life. The diagnosis was confirmed by the demonstration of increased plasma homocyst(e)ine (homocystine plus homocysteine) and methionine and decreased plasma cyst(e)ine (cystine plus cysteine).3 Cystathionine-13-synthetase activity was assayed in cultured skin fibroblasts of seven randomly chosen patients (Tables 1 and 2 ). The pyridoxine status of all patients was determined.
All patients attend the Inherited Metabolic Unit. One patient (case 17) responded to pyridoxine and folate supplements. The remainder required a lowmethionine diet supplemented with cystine. The diet was monitored and adjusted in accordance with monthly or bimonthly measurement of plasma methionine, homocyst(e)ine, and cyst(e)ine. The diagnosis of homocystinuria may be difficult, as the age of onset, severity, and pattern of clinical manifestations vary widely among affected patients. 12 Likewise homocystine levels vary widely, and tests based on methionine loading may confirm the diagnosis in suspected cases missed on routine screening.'3 The typical untreated homocystinuric is asymptomatic in infancy and subsequently develops ectopia lentis, mental retardation, skeletal disorders, and thromboembolic episodes which may be fatal. The prevalence and natural history of these complications remain uncertain owing to the short interval between original discovery and initiation of various therapies. Present limited evidence indicates that the advent of effective neonatal screening programmes, combined with the introduction of effective diet and pharmacological therapy in the neonatal period, has improved the prognosis. However, the ophthalmic benefit of treatment initiated in the newborn period remains uncertain because of the small numbers of patients studied so far.
None of our 14 patients detected on routine screening and started on dietary treatment within six weeks of birth have developed ectopia lentis over a mean follow-up of 8-2 years. Mudd et al. I suggest that the probability of ectopia lentis developing in untreated pyridoxine-unresponsive patients by 8.2 years is in excess of 70%. However, two poorly controlled patients within this group (cases 12 and 13) have recently developed myopia. This may be the harbinger of ectopia lentis in this subgroup, and longer follow-up is required.
The outcome in late detected cases whose treatment is initiated prior to the development of ectopia lentis is not clear, but two such cases (18 and 19) in our series developed ectopia lentis despite tight biochemical control within 1-5 and 0-5 years of initiation of therapy. Boers'4 followed up five such pyridoxine-responsive cases for periods ranging from 0-5 to 13 years and none developed ectopia lentis.
Grobe'5 suggests that ectopia lentis occurs in such cases but to a milder degree. Mudd et al.5 state that therapy may reduce the lens dislocation rate in pyridoxine-responsive cases but may not confer statistically significant benefit on lens dislocation in pyridoxine-unresponsive patients. It is clear from our present data that ectopia lentis progresses despite tight biochemical control in late detected cases.
Ectopia lentis is bilateral in the vast majority of patients with homocystinuria. Case 18 in our series developed unilateral ectopia lentis within 18 months of beginning a diet and has been followed up for four years with no change in the position of the contralateral lens to date.
Benign peripheral cystoid retinal degeneration extending circumferentially to the globe equator occurred in six of our 19 patients. No case progressed to degenerative retinoschisis. Ramsay and colleagues'6 suggest on the basis of histological studies that, in addition to ectopia lentis, peripheral cystoid retinal degeneration may also be observed as a characteristic clinical finding in some cases of homocystinuria. They also suggest that the pathogenesis of cystoid degeneration and that of ectopia lentis may be interrelated because of their common embryological origin. They note that the severity of the changes are age related and depend on patient survival. Peripheral cystoid retinal degeneration is the most common peripheral degeneration'7 present to some degree in all eyes after 8 years of age and gradually increases with age. In contrast to ectopia lentis and myopia we found no relationship between the age at start of treatment, adequacy of biochemical control, and peripheral cystoid retinal degeneration; but the number of patients are small and the follow-up period is relatively short. It is possible that patients with homocystinuria on an altered amino acid intake may be more susceptible to an acceleration of an otherwise common degenerative process.
Ocular complications are common in patients with homocystinuria. Ectopia lentis is the most significant in that it occurs in almost all cases, impairs visual acuity, and precipitates secondary sight threatening complications, including secondary glaucoma and retinal detachment. Lens extraction is probably associated with a greater incidence of ocular complications such as retinal detachment, and with intraand postoperative mortality due to thromboembolic episodes. Newborn screening followed by tight biochemical control prevented ectopia lentis in 11 of 14 patients (mean follow-up 8-2 years). Myopia without ectopia lentis occurred in two of 14 patients with less tight biochemical control. In contrast, ectopia lentis developed and progressed in five late-detected patients despite tight biochemical control. These results suggest that early treatment may significantly and beneficially alter the natural ophthalmic course of homocystinuric patients. The relationship between peripheral retinal changes and homocystinuria requires further evaluation.
